Skip to content
Screener

Biodesix, Inc. BDSX Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$7.27M+36.6%-$7.79M+29.8%-$3.98M+51.8%-$8.72M+15.0%-$11.47M-6.1%
$1.39M-3.5%$1.4M-3.1%$1.39M-4.3%$1.41M-5.8%$1.44M+1.8%
$820K-21.1%$1.12M+14.7%$1.08M-15.0%$1.05M-30.5%$1.04M-14.7%
-$1.56M+76.2%-$10.17M-18.2%$0+100%-$8.88M+16.8%-$6.57M+64.6%
$197K+286%$81K+9.5%$86K-89.7%$48K-79.2%$51K-97.4%
-$254K-167%-$144K-5.1%-$104K+88.2%-$67K+76.6%-$95K+95.2%
$1K-80.0%$5K-28.6%$5K-61.5%$4K-69.2%$5K-58.3%
$6.24M-36.3%$16.9M+17,320%$1.71M$4.82M+3,249%$9.79M-80.9%
$4.42M$6.59M+176%-$4.12M+61.9%
-$1.76M+73.4%-$10.25M-18.1%$0+100%-$8.93M+18.1%-$6.62M+67.7%

FAQ

How much cash does Biodesix, Inc. generate?
Biodesix, Inc. (BDSX) generated -$20.6M in operating cash flow over the trailing twelve months.
What is Biodesix, Inc.'s free cash flow?
After $412.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$20.9M over the trailing twelve months, up 32.8% year over year.
Where does Biodesix, Inc.'s cash flow data come from?
Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.